Chloramphenicol Sodium Succinate (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Chloramphenicol Sodium Succinate drug offered from Fresenius Kabi USA, LLC. This Amphenicol-class Antibacterial [EPC],Amphenicols [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: CHLORAMPHENICOL SODIUM SUCCINATE
SUBSTANCE NAME: CHLORAMPHENICOL SODIUM SUCCINATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Amphenicol-class Antibacterial [EPC],Amphenicols [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2001-01-12
END MARKETING DATE: 0000-00-00


Chloramphenicol Sodium Succinate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionChloramphenicol Sodium Succinate from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/10mL)
START MARKETING DATE: 2001-01-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-011_00bd45d9-faa9-442c-a66b-3d18c004cfcc
PRODUCT NDC: 63323-011
APPLICATION NUMBER: ANDA062365

Other CHLORAMPHENICOL SODIUM SUCCINATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCChloramphenicol Sodium Succinate